Overview Financials News + Filings IR Vault Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
CC transcript
Appointed director
|
|
Astex Pharmaceuticals, Inc (ASTX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/11/2013 |
8-K
| Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta... |
| 09/05/2013 |
8-K
| Quarterly results |
| 08/01/2013 |
8-K
| Quarterly results |
| 04/29/2013 |
8-K
| Quarterly results |
| 10/30/2012 |
8-K
| Quarterly results |
| 09/28/2012 |
8-K
| Other Events, Financial Statements and Exhibits |
| 07/30/2012 |
8-K
| Form 8-K - Current report |
| 06/28/2012 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...|
Docs:
|
"Contract of Employment effective June 22, 2012 by and between Astex Therapeutics Limited and Dr. Harren Jhoti",
"Confidentiality and Proprietary Information Deed effective June 22, 2012 by and between Astex Pharmaceuticals, Inc., Astex Therapeutics Limited, and Dr. Harren Jhoti",
"Contract of Employment effective June 22, 2012 by and between Astex Therapeutics Limited and Martin Buckland",
"Confidentiality and Proprietary Information Deed effective June 22, 2012 by and between Astex Pharmaceuticals, Inc., Astex Therapeutics Limited, and Martin Buckland",
"Severance Benefit Plan for Officers effective June 22, 2012" |
|
| 06/25/2012 |
8-K
| Submission of Matters to a Vote of Security Holders |
| 04/30/2012 |
8-K
| Quarterly results |
| 03/13/2012 |
8-K
| Form 8-K - Current report |
| 03/05/2012 |
8-K
| Form 8-K - Current report |
| 01/20/2012 |
8-K
| Form 8-K - Current report |
| 10/31/2011 |
8-K
| Form 8-K - Current report |
| 08/03/2011 |
8-K
| Form 8-K - Current report |
| 07/20/2011 |
8-K
| Appointed a new director|
Docs:
|
"SuperGen Completes Acquisition of Astex Therapeutics DUBLIN, Calif., July 20, 2011 — SuperGen, Inc. , a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, announced it has closed the transaction to acquire Astex Therapeutics Limited , a privately held, UK-based biotechnology company developing targeted therapies. Today, Astex Therapeutics Limited became a wholly owned subsidiary of SuperGen, Inc. SuperGen purchased all outstanding shares of Astex for approximately $25 million in cash and 32.4 million shares of SuperGen common stock representing 35 percent of the total post closing shares outstanding. In addition, SuperGen will pay deferred consideration in the amount of $30 million in either stock or cash, at the discretion of the combined entity, ...",
"Employment Agreement between Astex Technology Limited and Harren Jhoti (Astex Technology Limited changed its name to Astex Therapeutics Limited on June 27, 2005)",
"Employment Agreement between Astex Technology Limited and Martin Buckland (Astex Technology Limited changed its name to Astex Therapeutics Limited on June 27, 2005)" |
|
| 06/16/2011 |
8-K
| Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits|
Docs:
|
"SuperGen Stockholders Approve Stock Issuance In Connection with the Proposed Acquisition of Astex Therapeutics Limited DUBLIN, Calif., June 16, 2011 — SuperGen, Inc. , a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, announced that stockholders have approved the issuance of shares to be issued in connection with the proposed acquisition of Astex Therapeutics Limited , a privately held, U.K.-based biotechnology company developing targeted therapies. The proposal to approve the share issuances in connection with the proposed acquisition of Astex passed by those voting either in person or by proxy at SuperGen's annual meeting of stockholders on June 16, 2011. On June 13, 2011, the shareholders of Astex voted to approve the transaction. “We are ver..." |
|
| 04/27/2011 |
8-K
| Form 8-K - Current report |
| 04/06/2011 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits|
Docs:
|
"Implementation Agreement, between SuperGen, Inc., and Astex Therapeutics Limited, a UK corporation, (certain schedules have been omitted pursuant to Item 601(b)(2) of Regulation S-K and will be provided to the Securities and Exchange Commission upon request)",
"Form of Support Agreement among Astex Therapeutics Limited, a UK corporation, and certain stockholders of SuperGen, Inc",
"SUPERGEN AND ASTEX THERAPEUTICS ENTER DEFINITIVE MERGER AGREEMENT" |
|
| 03/28/2011 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 03/18/2011 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits |
| 03/11/2011 |
8-K
| Form 8-K - Current report |
| 02/28/2011 |
8-K
| Quarterly results |
| 10/25/2010 |
8-K
| Form 8-K - Current report |
| 10/04/2010 |
8-K
| Form 8-K - Current report |
| 08/06/2010 |
8-K
| Form 8-K - Current report |
| 08/02/2010 |
8-K
| Quarterly results |
| 06/14/2010 |
8-K
| Submission of Matters to a Vote of Security Holders |
| 04/26/2010 |
8-K
| Quarterly results |
| 03/19/2010 |
8-K
| Form 8-K - Current report |
| 03/01/2010 |
8-K
| Quarterly results |
| 01/22/2010 |
8-K
| Form 8-K - Current report |
| 10/28/2009 |
8-K
| Form 8-K - Current report |
| 10/26/2009 |
8-K
| Quarterly results |
|
|
|